Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > LATEST
LATEST
-
REGULATORY Japan Restarts Deliberations on Routine Mumps Vaccination, Eyes FY2027 Rollout
June 22, 2026
-
ORGANIZATION Think Tank Opposes Cap on Social Security Burden Ratio, Urges Pause in Off-Year Price Cuts
June 22, 2026
-
REGULATORY LDP Group Calls for Pediatric Cancer Drug Development Platform
June 22, 2026
-
REGULATORY LDP Group Seeks Better Access to Advanced Eczema Care
June 22, 2026
-
REGULATORY Japan Panel Backs Revaccination after Allogeneic Stem Cell Transplantation
June 22, 2026
-
BUSINESS Shionogi’s CEO Pay Up at 302 Million Yen in FY2025
June 22, 2026
-
BUSINESS J-TEC Sets Up German Unit to Expand LabCyte Biz in Europe
June 22, 2026
-
REGULATORY MHLW to Carefully Prepare Rollout of OTC-Like Drug Charge System
June 22, 2026
-
BUSINESS Daiichi Sankyo CEO’s Pay Rises to 273 Million Yen in FY2025
June 22, 2026
-
REGULATORY LDP, Ishin Still at Odds on Social Security Reform; Pharma Role in Chuikyo Gains Traction
June 19, 2026
-
REGULATORY MHLW Panel OKs Technical Review Group for OTC-Like Drug Charge System
June 19, 2026
-
BUSINESS Shionogi/F2G’s Novel Antifungal Makes Mark, New Option in Resistant Cases
June 19, 2026
-
REGULATORY MHLW Official Warns of High Risks from GLP-1 Use in Cosmetic Weight Loss
June 19, 2026
-
BUSINESS Axcelead Joins Lilly’s TuneLab AI Drug Discovery Platform
June 19, 2026
-
BUSINESS Create BioVentures Sets Sail as Drug Discovery Bridge Builder
June 19, 2026
-
BUSINESS Merck Japan Expands Fertility Benefits, Raises Lifetime Cap to 18 Million Yen
June 19, 2026
-
REGULATORY LDP to Launch Study Group on Lag and Loss of Pediatric Cancer Drugs
June 19, 2026
-
REGULATORY LDP Patch League Urges Drug Price Support as Costs Continue to Climb
June 19, 2026
-
BUSINESS Santen CEO Paid 251 Million Yen in FY2025, COO Joins Disclosure List
June 19, 2026
-
ORGANIZATION Japanese Drug Makers Step Up Use of ASEAN Reliance Reviews
June 18, 2026
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…